Celltrion Pharm, Inc. (068760.KQ)
KRW 61300.0
(-3.01%)
KRW 61300.0
(-3.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 388.79 Billion | 386.03 Billion | 398.73 Billion | 233.56 Billion | 173.51 Billion | 146.88 Billion |
| Cost of Revenue | 271.83 Billion | 274.38 Billion | 280.49 Billion | 161.87 Billion | 112.7 Billion | 107.61 Billion |
| Gross Profit | 116.95 Billion | 111.65 Billion | 118.24 Billion | 71.69 Billion | 60.8 Billion | 39.26 Billion |
| Operating Expenses | 80.93 Billion | 73.48 Billion | 70.46 Billion | 48.06 Billion | 46.07 Billion | 36.1 Billion |
| Selling, General and Administrative Expenses | 35.17 Billion | 65.48 Billion | 64.09 Billion | 43.45 Billion | 43.93 Billion | 34.18 Billion |
| Research and Development Expenses | 12.7 Billion | 7.99 Billion | 6.36 Billion | 4.61 Billion | 2.13 Billion | 1.91 Billion |
| Other Expenses | 35.75 Billion | -1.06 Billion | 49.54 Million | 121.27 Million | - | - |
| Cost and Expenses | 352.77 Billion | 347.86 Billion | 350.95 Billion | 209.93 Billion | 158.77 Billion | 143.71 Billion |
| Operating Income | 36.07 Billion | 38.17 Billion | 47.78 Billion | 23.63 Billion | 14.73 Billion | 3.16 Billion |
| Interest Expense | 8.29 Billion | 6.21 Billion | 5.35 Billion | 4.58 Billion | 5.69 Billion | 5.96 Billion |
| Income Tax Expense | 4.94 Billion | 4.5 Billion | 7.94 Billion | -811.82 Million | 242.68 Million | 3.12 Billion |
| Earnings before Tax | 26.2 Billion | 30.46 Billion | 42.52 Billion | 20.12 Billion | 8.84 Billion | -6.26 Billion |
| Net Income | 21.26 Billion | 25.95 Billion | 34.57 Billion | 20.93 Billion | 8.6 Billion | -9.38 Billion |
| Earnings Per Share Basic | 539.00 | 626.83 | 834.84 | 505.43 | 218.08 | -226.92 |
| Earnings Per Share Diluted | 539.00 | 625.32 | 830.36 | 503.17 | 217.41 | -226.92 |
| Weighted Average Shares Outstanding | 39.45 Million | 41.41 Million | 41.41 Million | 41.42 Million | 39.44 Million | 41.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.45 Million | 41.51 Million | 41.64 Million | 41.61 Million | 39.56 Million | 41.37 Million |
| Gross Margin | 0.30 | 0.29 | 0.30 | 0.31 | 0.35 | 0.27 |
| EBIT Margin | 0.14 | 0.14 | 0.16 | 0.16 | 0.16 | 0.11 |
| Profit Margin | 0.05 | 0.07 | 0.09 | 0.09 | 0.05 | -0.06 |
| EBITDA | 54.22 Billion | 54.1 Billion | 64.25 Billion | 37.1 Billion | 27.76 Billion | 12.41 Billion |
| Earnings Before Tax Margin | 0.09 | 0.10 | 0.12 | 0.10 | 0.08 | 0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 117.15 Billion | 96.96 Billion | 388.79 Billion | 95.15 Billion | 93.38 Billion | 110.24 Billion |
| Cost of Revenue | 88.56 Billion | 73.97 Billion | 271.83 Billion | 69.4 Billion | 64.85 Billion | 75.2 Billion |
| Gross Profit | 28.59 Billion | 22.99 Billion | 116.95 Billion | 25.74 Billion | 28.52 Billion | 35.04 Billion |
| Operating Expenses | 19.17 Billion | 19.3 Billion | 80.93 Billion | 20.6 Billion | 21.97 Billion | 20.26 Billion |
| Selling, General and Administrative Expenses | 16.17 Billion | 16.29 Billion | - | 16.56 Billion | 17.2 Billion | 18.11 Billion |
| Research and Development Expenses | 2.99 Billion | 3 Billion | - | 4.04 Billion | 4.76 Billion | 2.14 Billion |
| Other Expenses | -20.18 Billion | -1.22 Million | 93.15 Million | -74.59 Million | 40.58 Million | 82.64 Million |
| Cost and Expenses | 107.73 Billion | 93.27 Billion | 352.77 Billion | 90.01 Billion | 86.83 Billion | 95.47 Billion |
| Operating Income | 9.41 Billion | 3.68 Billion | 36.02 Billion | 5.14 Billion | 6.55 Billion | 14.77 Billion |
| Interest Expense | 1.83 Billion | 1.86 Billion | 8.29 Billion | 2.16 Billion | 1.99 Billion | 2.09 Billion |
| Income Tax Expense | 1.99 Billion | 115.5 Million | 4.94 Billion | 82.07 Million | 1.18 Billion | 2.62 Billion |
| Earnings before Tax | 7.58 Billion | 2 Billion | 26.2 Billion | 791.16 Million | 4.48 Billion | 13.18 Billion |
| Net Income | 5.59 Billion | 1.89 Billion | 21.26 Billion | 709.08 Million | 3.3 Billion | 10.56 Billion |
| Earnings Per Share Basic | 135.10 | 45.65 | - | 17.12 | 79.75 | 255.08 |
| Earnings Per Share Diluted | 134.94 | 45.57 | - | 17.12 | 79.67 | 254.79 |
| Weighted Average Shares Outstanding | 41.38 Million | 41.41 Million | 41.41 Million | 41.41 Million | 41.41 Million | 41.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.43 Million | 41.48 Million | 41.46 Million | 41.41 Million | 41.45 Million | 41.45 Million |
| Gross Margin | 0.24 | 0.24 | 0.30 | 0.27 | 0.31 | 0.32 |
| EBIT Margin | 0.12 | 0.09 | - | 0.11 | 0.13 | 0.18 |
| Profit Margin | 0.05 | 0.02 | 0.05 | 0.01 | 0.04 | 0.10 |
| EBITDA | 14.41 Billion | 8.82 Billion | - | 10.38 Billion | 11.8 Billion | 19.63 Billion |
| Earnings Before Tax Margin | 0.08 | 0.04 | 0.09 | 0.05 | 0.07 | 0.13 |
B52
603196
RRR
FMCCI
FLXI
PPG